Adverse events232

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 232

Type	Event	Organ system	Group	Affected	At risk	Events
other	Gastritis	Gastrointestinal disorders	Benralizumab Dose 1, Aged 6-11 Years	0	15	0
other	Gastritis	Gastrointestinal disorders	Benralizumab Dose 2, Aged 6-11 Years	0	13	0
other	Gastritis	Gastrointestinal disorders	Benralizumab Dose 1, Aged 6-14 Years	0	15	0
other	Gastritis	Gastrointestinal disorders	Benralizumab Dose 2, Aged 6-14 Years	1	15	1
other	Gastrooesophageal reflux disease	Gastrointestinal disorders	Benralizumab Dose 1, Aged 6-11 Years	0	15	0
other	Gastrooesophageal reflux disease	Gastrointestinal disorders	Benralizumab Dose 2, Aged 6-11 Years	0	13	0
other	Gastrooesophageal reflux disease	Gastrointestinal disorders	Benralizumab Dose 1, Aged 6-14 Years	0	15	0
other	Gastrooesophageal reflux disease	Gastrointestinal disorders	Benralizumab Dose 2, Aged 6-14 Years	1	15	1
other	Vomiting	Gastrointestinal disorders	Benralizumab Dose 1, Aged 6-11 Years	2	15	2
other	Vomiting	Gastrointestinal disorders	Benralizumab Dose 2, Aged 6-11 Years	0	13	0
other	Vomiting	Gastrointestinal disorders	Benralizumab Dose 1, Aged 6-14 Years	2	15	2
other	Vomiting	Gastrointestinal disorders	Benralizumab Dose 2, Aged 6-14 Years	0	15	0
other	Chills	General disorders	Benralizumab Dose 1, Aged 6-11 Years	1	15	1
other	Chills	General disorders	Benralizumab Dose 2, Aged 6-11 Years	0	13	0
other	Chills	General disorders	Benralizumab Dose 1, Aged 6-14 Years	1	15	1
other	Chills	General disorders	Benralizumab Dose 2, Aged 6-14 Years	0	15	0
other	Fatigue	General disorders	Benralizumab Dose 1, Aged 6-11 Years	1	15	1
other	Fatigue	General disorders	Benralizumab Dose 2, Aged 6-11 Years	0	13	0
other	Fatigue	General disorders	Benralizumab Dose 1, Aged 6-14 Years	1	15	1
other	Fatigue	General disorders	Benralizumab Dose 2, Aged 6-14 Years	0	15	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04305405/events

API reference For AI assistants

Adverse events232

Sources 3

Read this list from software.